Autonomix Medical (AMIX) Cash from Financing Activities (2023 - 2025)
Autonomix Medical (AMIX) posted quarterly Cash from Financing Activities of $5.4 million for Q4 2025, down 39.46% year-over-year from $9.0 million in Q4 2024, and up 100.85% quarter-over-quarter from $2.7 million in Q3 2025.
Autonomix Medical (AMIX) Cash from Financing Activities (2023 - 2025) Analysis & Trends
Autonomix Medical (AMIX) has reported Cash from Financing Activities for 3 consecutive years, with $5.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash from Financing Activities fell 39.46% year-over-year to $5.4 million; the TTM figure through Dec 2025 stood at $19.0 million (down 18.77% YoY), while the FY2024 annual figure was $14.4 million, up 2034.81% from the prior year.
- Cash from Financing Activities advanced to $5.4 million in Q4 2025 per AMIX's latest filing, from $2.7 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $14.4 million in Q1 2024 and bottomed at $350000.0 in Q3 2023.
- Historically, Cash from Financing Activities has averaged $4.8 million across 3 years, with a median of $2.7 million in 2023.
- Annual changes were most pronounced in 2024 — Cash from Financing Activities soared 2034.81% — and 2025, when it sank 39.46%.
- Autonomix Medical's Cash from Financing Activities stood at $1.6 million in 2023, then surged by 445.53% to $9.0 million in 2024, then tumbled by 39.46% to $5.4 million in 2025.
- Business Quant data shows AMIX's Cash from Financing Activities at $5.4 million in Q4 2025, $2.7 million in Q3 2025, and $2.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Autonomix Medical | 2.33 Mn | -4.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.43 Mn |
| Dec 31, 2025 | 5.43 Mn |
| Sep 30, 2025 | 2.71 Mn |
| Sep 30, 2025 | 2.71 Mn |
| Jun 30, 2025 | 2.06 Mn |
| Jun 30, 2025 | 2.06 Mn |
| Mar 31, 2025 | 8.80 Mn |
| Mar 31, 2025 | 8.80 Mn |
| Dec 31, 2024 | 8.97 Mn |
| Dec 31, 2024 | 8.97 Mn |
| Mar 31, 2024 | 14.41 Mn |
| Mar 31, 2024 | 14.41 Mn |
| Dec 31, 2023 | 1.65 Mn |
| Dec 31, 2023 | 1.65 Mn |
| Sep 30, 2023 | 350,000.00 |
| Sep 30, 2023 | 350,000.00 |
| Jun 30, 2023 | 2.74 Mn |
| Jun 30, 2023 | 2.74 Mn |
| Mar 31, 2023 | 675,000.00 |
| Mar 31, 2023 | 675,000.00 |